Expression of cyclooxygenase-2 and DNA topoisomerase II α in precancerous and cancerous lesions of the oral mucosa

Oral Oncology

Volumn 44, Issue 7, 2008, Pages 664-671

  Segawa, Emi ^a   Sakurai, Kazunari ^a   Kishimoto, Hiromitsu ^a   Takaoka, Kazuki ^a   Noguchi, Kazuma ^a   Hashitani, Susumu ^a   Hirota, Seiichi ^a   Urade, Masahiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

COX 2; DNA Topo II ; Oral mucosa; Precancerous and cancerous lesions

Indexed keywords

CYCLOOXYGENASE 2; DNA TOPOISOMERASE (ATP HYDROLYSING);

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CELL PROLIFERATION; ENZYME ACTIVITY; EPITHELIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; MOUTH MUCOSA; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UNDIFFERENTIATED CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CYCLOOXYGENASE 2; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; SURVIVAL ANALYSIS;

EID: 45249106157     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.08.014     Document Type: Article

References (49)

1. Pindborg J.J. Atlas of diseases of the oral mucosa. 5th ed. (1992), WB Saunders, Philadelphia
2. Ahmedin J., Ram C.T., Taylor M., Asma G., Alicia S., Elizabeth W., et al. Cancer statistics. CA Cancer J Clin 54 (2004) 8-29
3. Von Dongen G.A., and Snow G.B. Prospectives for future studies in head and neck cancer. Eur J Surg Oncol 23 (1997) 485-491
4. Regezi J.A., Sciubba J.J., and Jordan R.C. Oral pathology. 4th ed. (2003), Saunders, St Louis, Mo p. 52-71
5. Forastiere A., Koch W., and Trotti A. Medical progress: head and neck cancer. N Engl J Med 345 (2001) 1890-1900
6. Kargman S.L., O'Neill G.P., Vickers P.J., Evans J.F., Mancini J.A., and Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55 12 (1995) 2556-2559
7. Ristimaki A., Honkanen N., Jankala H., Sipponen P., and Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57 7 (1997) 1276-1280
8. Parrett M.L., Harris R., Joarder F.S., Ross M.S., Clausen K.P., and Robertson F.M. Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol 10 (1997) 503-507
9. Hida T., Yatabe Y., Achiwa H., Muramatsu H., Kozaki K., Nakamura S., et al. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancer, specifically in adenocarcinomas. Cancer Res 58 17 (1998) 3761-3764
10. Zimmermann K.C., Sarbia M., Weber A.A., Borchard F., Gabbert H.E., and Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59 1 (1999) 198-204
11. Tucker O.N., Dannenberg A.J., Yang E.K., Zhang F., Teng L., Daly J.M., et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59 5 (1999) 987-990
12. Shirahama T., and Sakakura C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin Cancer Res 7 3 (2001) 558-561
13. Yoshimura R., Sano H., Masuda C., Kawamura M., Tsubouchi Y., Chargui J., et al. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 89 3 (2000) 589-596
14. Chan G., Boyle J.O., Yang E.K., Zhang F., Sacks P.G., Shah J.P., et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res 59 (1999) 991-994
15. Sakurai K., Urade M., Noguchi K., Kishimoto H., Ishibashi M., Yasoshima H., et al. Increased expression of cyclooxygenase-2 in human salivary gland tumors. Pathol Int 51 (2001) 762-769
16. Peng J., Su C., Chang H.C., Chai C.Y., and Hung W.C. Overexpression of cyclooxygenase 2 in squamous cell carcinoma of the hypopharynx. Hum Pathol 33 (2002) 100-104
17. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271 52 (1996) 33157-33160
18. Pindborg J.J., Reichart P.A., Smith C.J., and van der Waal I. Histological typing of cancer and precancer of the oral mucosa. 2nd ed. (1997), Springer-Verlag, Berlin
19. Sobin L.H., and Wittekind C. TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, New York
20. Wood G.D., and Warnke R. Suppression of endogenous avidin binding activity in tissue and its relevance to biotin-avidin detection system. J Histochem Cytochem 29 10 (1981) 1196-1204
21. Wolff H., Saukkonen K., Anttila S., Karjalainen A., Vainio H., and Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58 22 (1998) 4997-5001
22. Mohammed S.I., Knapp D.W., Bostwick D.G., Foster R.S., Khan K.N., Masferrer J.L., et al. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res 59 22 (1999) 5647-5650
23. Takahashi M., and Wakabayashi K. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 95 6 (2004) 475-480
24. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 36 3 (2000) 256-263
25. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol 36 4 (2000) 311-327
26. Scully C., Field J.K., and Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications. Oral Oncol 36 5 (2000) 404-413
27. Shibata M., Kodani I., Osaki M., Araki K., Adachi H., Ryoke K., et al. Cyclooxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol 41 3 (2005) 304-312
28. Nathan C.O., Leskov I.L., Lin M., Abreo F.W., Shi R., Hartman G.H., et al. COX-2 expression in dysplasia of the head and neck: correlation with elF4E. Cancer 92 7 (2001) 1888-1895
29. Goswami P.C., Roti J.L., and Hunt C.R. The cell cycle-coupled expression of topoisomeraseII α during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation. Mol Cell Biol 16 4 (1996) 1500-1508
30. Woessner R.D., Mattern M.R., Mirabell C.K., Johnson R.K., and Drake F.H. Proliferation- and cell-cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomeraseII in NIH-3T3 cells. Cell Growth Differ 2 4 (1991) 209-214
31. Holden J.A. DNA topoisomeraseII α as a proliferation marker in endocrine and other neoplasms. Endocr Pathol 10 (1999) 97-102
32. Ratnasinghe D., Tangrea J., Roth M.J., Dawsey S., Hu N., Anver M., et al. Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res 19 1A (1999) 171-174
33. Ranelletti F.O., Almadori G., Rocca B., Ferrandina G., Ciabattoni G., Habib A., et al. Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. Int J Cancer 95 (2001) 343-349
34. Renkonen J., Wolff H., and Paavonen T. Expression of cyclooxygenase-2 in human tongue carcinoma and its precursor lesions. Virchows Arch 440 6 (2002) 594-597
35. Nozoe T., Ezaki T., Kabashima A., Baba H., and Maehara Y. Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus. Am J Surg 189 1 (2005) 110-115
36. Kuroda J., Urade M., Kishimoto H., Noguchi K., Hashitani S., Sakurai K., et al. Promotion of cell differentiation, and suppression of cell growth and cyclooxygenase-2 expression by differentiation-inducing agents in human oral squamous carcinoma SCC25 cells. Int J Oncol 26 2 (2005) 361-367
37. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 4 (1994) 1183-1188
38. Sudbo J., Ristimaki A., Sondresen J.E., Kildal W., Boysen M., Koppang H.S., et al. Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions. Oral Oncol 39 5 (2003) 497-505
39. Sheehan K.M., Sheahan K., O'Donoghue D.P., MacSweeney F., Conroy R.M., Fitzgerald D.J., et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA 282 13 (1999) 1254-1257
40. Tomozawa S., Tsuno N.H., Sunami E., Hatano K., Kitayama J., Osada T., et al. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer. Brit J Cancer 83 3 (2000) 324-328
41. Masunaga R., Kohno H., Dhar D.K., Ohno S., Shibakita M., Kinugasa S., et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 6 10 (2000) 4064-4068
42. Konno H., Bada M., Shoji T., Ohta M., Suzuki S., and Nakamura S. Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer. Clin Exp Metastasis 19 6 (2002) 527-534
43. Joo Y.E., Kim H.S., Min S.W., Lee W.S., Park C.H., Park C.S., et al. Expression of cyclooxygenase-2 protein in colorectal carcinomas. Int J Gastrointest Cancer 31 1-3 (2002) 147-154
44. Petersen S., Haroske G., Hellmich G., Ludwig K., Petersen C., and Eicheler W. COX-2 expression in rectal carcinoma: immunohistochemical pattern and clinical outcome. Anticancer Res 22 2B (2002) 1225-1230
45. Zhang H., and Sun X.F. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Am J Gastroenterol 97 4 (2002) 1037-1041
46. Fux R., Schwab M., Thon K.-P., Gleiter C.H., and Fritz P. Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival. Clin Cancer Res 11 13 (2005) 4754-4760
47. Gallo O., Masini E., Bianchi B., Bruschini L., Paglierani M., and Franchi A. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Hum Pathol 33 7 (2002) 708-714
48. Chang B.W., Kim D.H., Kowalski D.P., Burleson J.A., Son Y.H., Wilson L.D., et al. Prognostic significance of cyclooxygenase-2 in oropharyngeal squamous cell carcinoma. Clin Cancer Res 10 5 (2004) 1678-1684
49. Sakurai K, Urade M, Noguchi K, Hashitani S, Takaoka K, Segawa E, et al. Prognostic significance of cyclooxygenase-2 and DNA Topoisomerase II α expression in oral carcnoma. Head Neck 2007; Apr 11: [Epub ahead of print].